ATE311870T1 - Liposomformulationen mit busulphan - Google Patents

Liposomformulationen mit busulphan

Info

Publication number
ATE311870T1
ATE311870T1 AT99931721T AT99931721T ATE311870T1 AT E311870 T1 ATE311870 T1 AT E311870T1 AT 99931721 T AT99931721 T AT 99931721T AT 99931721 T AT99931721 T AT 99931721T AT E311870 T1 ATE311870 T1 AT E311870T1
Authority
AT
Austria
Prior art keywords
formulations
busulphan
parenteral administration
liposome formulations
encapsulated
Prior art date
Application number
AT99931721T
Other languages
English (en)
Inventor
Moustapha Hassan
Original Assignee
Hassan Moustapha Dr
Hassan Zusana
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9802197A external-priority patent/SE9802197D0/xx
Application filed by Hassan Moustapha Dr, Hassan Zusana filed Critical Hassan Moustapha Dr
Application granted granted Critical
Publication of ATE311870T1 publication Critical patent/ATE311870T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Insulating Materials (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
AT99931721T 1998-06-18 1999-06-17 Liposomformulationen mit busulphan ATE311870T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8975998P 1998-06-18 1998-06-18
SE9802197A SE9802197D0 (sv) 1998-06-18 1998-06-18 Formulations of busulphan
PCT/SE1999/001093 WO1999065481A1 (en) 1998-06-18 1999-06-17 Liposomal formulations of busulphan

Publications (1)

Publication Number Publication Date
ATE311870T1 true ATE311870T1 (de) 2005-12-15

Family

ID=26663332

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99931721T ATE311870T1 (de) 1998-06-18 1999-06-17 Liposomformulationen mit busulphan

Country Status (6)

Country Link
EP (1) EP1089727B8 (de)
JP (1) JP2002518322A (de)
AT (1) ATE311870T1 (de)
AU (1) AU4815699A (de)
DE (1) DE69928805T2 (de)
WO (1) WO1999065481A1 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1338702C (en) * 1987-03-05 1996-11-12 Lawrence D. Mayer High drug:lipid formulations of liposomal- antineoplastic agents
EP0660714B1 (de) * 1991-06-18 2003-07-02 ImaRx Pharmaceutical Corp. Neue liposomale arzneimittelfreisetzungssysteme
EP0546951A1 (de) * 1991-12-13 1993-06-16 The Liposome Company, Inc. Kombination von im Liposomen verkapselten antineoplastischen Mitteln wie Doxorubicin, mit Kolonie-stimulierenden Faktoren
US5430057A (en) * 1993-09-30 1995-07-04 Board Of Regents, The University Of Texas System Parenteral busulfan for treatment of malignant disease

Also Published As

Publication number Publication date
WO1999065481A1 (en) 1999-12-23
JP2002518322A (ja) 2002-06-25
DE69928805D1 (en) 2006-01-12
EP1089727B8 (de) 2006-03-08
DE69928805T2 (de) 2006-08-31
EP1089727B1 (de) 2005-12-07
EP1089727A1 (de) 2001-04-11
AU4815699A (en) 2000-01-05

Similar Documents

Publication Publication Date Title
PL347671A1 (en) Compounds and compositions for delivering active agents
EP1100522A4 (de) Verabreichung aktiver wirkstoffe über die lunge
HK1034183A1 (en) Galenic formulations of meloxicam for oral administration.
MXPA01008611A (es) Compuestos y composiciones para suministrar agentes activos.
DE60038183D1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
IL166527A0 (en) Macrolide compounds endowed with antiinflammatory activity
HUP0204170A3 (en) 5-thia-omega-substituted phenyl-prostaglandin e derivatives, process for producing the same and drugs containing the same as the active ingredient
DE69713152D1 (de) Cyclosporinderivate, deren herstellung und pharmazeutische zusammensetzungen
DZ2887A1 (fr) Dérivés d'azétidine, leur préparation et les médicaments les contenant.
NO20014035L (no) System for oral administrasjon av medikament
IL153297A0 (en) Compounds and compositions for delivering active agents
HUP0203312A3 (en) Pharmaceutically active sulfonamide derivatives, process for their preparation, and pharmaceutical compositions and their use
ATE399171T1 (de) Camptothecinanaloge und deren zubereitungsmethoden
UY26372A1 (es) "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
BR0012429A (pt) Fórmulações para il-11
MY128362A (en) Spontaneously dispersible n-benzoyl staurosporine compositions
MY113203A (en) Lyophilizate of lipid complex of water insoluble camptothecins
ITMI20022292A1 (it) 9a-azalidi ad attivita' antiinfiammatoria.
AU5290199A (en) Erythromycin derivatives with antibiotic activity
AU9270598A (en) Hydrazono-benzazulene derivatives, pharmaceutical compositions and in termediates
ATE311870T1 (de) Liposomformulationen mit busulphan
SE9902742D0 (sv) New pharmaceutical formultion
AU5685300A (en) Solid preparations containing paroxetine
IT1257000B (it) Derivati dell'eserolina ad attivita` anticolinesterasica, procedimento per la loro preparazione e composizioni farmaceutiche cheli contengono.
ATE254625T1 (de) Eythromycinderivat mit antibiotischer aktvität

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties